Current Challenges in Mammalian Cell Processing
Learn how to design next generation mammalian cell processes and how to evaluate the impact of emerging and disruptive technologies.
22-24 January 2018
The increasing number of mAb and biosimilar products in the market has intensified competition and accelerated the rate of innovation across the sector.
This module aims to present, evaluate and consolidate the latest developments through a series of lectures and interactive case
studies that will enable you to:
- Understand the fundamentals governing productivity and product quality at industrial scale
- Assess the suitability of single use technologies as a replacement for existing unit operations
- Learn how to develop robust and reliable scale down models to assist in process development and characterization
- Learn about the latest trends in cell line development and media formulation
- Learn about process intensification, continuous bioprocessing and its current status and how to assess the impact of disruptive technologies
- Explore how mathematical models can be used to enhance process understanding and improve activities in process optimization
Who should attend?
The course is designed for scientists, engineers and managers working in the biotech/biopharma sector that are involved or interact with people in Process Development, Process Intensification, Process Characterization, Manufacturing and Quality Control.
Typically, delegates are:
Molecular biologists, process engineers, cell biologists, analytical scientists, project managers and chief scientific officers.
• Historic perspective of mammalian cell culture
• Rapid cell line development
• The design of highly productive processes
• Case Study: Strategies to optimise process economics
• Case study: from development to production
• Challenges for mammalian cell culture analytics
• Critical quality attributes of recombinant therapeutic
• Scale-down approaches to bioprocess development
• Use of mathmatical modes to improve bioprocesses
• Engineering fundamentals and mixing in single-use bioreactors
• Tutorial: Technology transfer and scale translation
• Developing the next generation mAbs processing enabled by single-use
• Workshop: Single-use bioprocess economics
• The impact of upstream production on downstream processing
Dr Alex Kiparissides - Module Leader
Dr Frank Baganz
Prof Suzanne Farid
Prof Gary Lye
Dr Martina Micheletti
Previous Expert Speakers Include
Suzanne Aldington, Lonza
Paul Beckett, Merck MilliporeJohn Birch, Consultant
Grant Grieve, Fujifilm Diosynth Biotechnologies
Colin Jaques, Lonza
Cleo Kontoravdi, Imperial College London
David Pollard, Merck & Co Inc.
Martin Smith, eXmoor Pharma Concepts
David Valentine, Lonza
For further information and bookings please contact:
T: +44 (0) 20 7679 9619 l +44 (0) 203 549 5619